108 related articles for article (PubMed ID: 21047106)
41. Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist.
Sarau HM; Griswold DE; Potts W; Foley JJ; Schmidt DB; Webb EF; Martin LD; Brawner ME; Elshourbagy NA; Medhurst AD; Giardina GA; Hay DW
J Pharmacol Exp Ther; 1997 Jun; 281(3):1303-11. PubMed ID: 9190866
[TBL] [Abstract][Full Text] [Related]
42. Fancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with subnanomolar binding affinity and novel selectivity profiles.
Schlotter K; Boeckler F; Hübner H; Gmeiner P
J Med Chem; 2005 Jun; 48(11):3696-9. PubMed ID: 15916420
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
[TBL] [Abstract][Full Text] [Related]
44. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
[TBL] [Abstract][Full Text] [Related]
45. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework.
Giardina GA; Sarau HM; Farina C; Medhurst AD; Grugni M; Raveglia LF; Schmidt DB; Rigolio R; Luttmann M; Vecchietti V; Hay DW
J Med Chem; 1997 Jun; 40(12):1794-807. PubMed ID: 9191956
[TBL] [Abstract][Full Text] [Related]
46. Differential effects of activation of peripheral and spinal tachykinin neurokinin(3) receptors on the micturition reflex in rats.
Kamo I; Chancellor MB; de Groat WC; Yoshimura N
J Urol; 2005 Aug; 174(2):776-81. PubMed ID: 16006975
[TBL] [Abstract][Full Text] [Related]
47. Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists.
Giardina GA; Artico M; Cavagnera S; Cerri A; Consolandi E; Gagliardi S; Graziani D; Grugni M; Hay DW; Luttmann MA; Mena R; Raveglia LF; Rigolio R; Sarau HM; Schmidt DB; Zanoni G; Farina C
Farmaco; 1999 Jun; 54(6):364-74. PubMed ID: 10443017
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
49. The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach.
Fan Y; Lai MH; Sullivan K; Popiolek M; Andree TH; Dollings P; Pausch MH
Bioorg Med Chem Lett; 2008 Nov; 18(21):5789-91. PubMed ID: 18849166
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of 2-(4-biphenylyl)quinoline-4-carboxylate and carboxamide analogs. New human neurokinin-3 (hNK-3) receptor antagonists.
Saudi MN; Rostom SA; Fahmy HT; El Ashmawy IM
Arch Pharm (Weinheim); 2003 Jun; 336(3):165-74. PubMed ID: 12822182
[TBL] [Abstract][Full Text] [Related]
51. Functional characterization of the nonpeptide neurokinin3 (NK3) receptor antagonist, SR142801 on the human NK3 receptor expressed in Chinese hamster ovary cells.
Oury-Donat F; Carayon P; Thurneyssen O; Pailhon V; Emonds-Alt X; Soubrié P; Le Fur G
J Pharmacol Exp Ther; 1995 Jul; 274(1):148-54. PubMed ID: 7616392
[TBL] [Abstract][Full Text] [Related]
52. Identification of novel NK1/NK3 dual antagonists for the potential treatment of schizophrenia.
Catalani MP; Alvaro G; Bernasconi G; Bettini E; Bromidge SM; Heer J; Tedesco G; Tommasi S
Bioorg Med Chem Lett; 2011 Nov; 21(22):6899-904. PubMed ID: 21974957
[TBL] [Abstract][Full Text] [Related]
53. Discovery of non-glycoside sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors by ligand-based virtual screening.
Wu JS; Peng YH; Wu JM; Hsieh CJ; Wu SH; Coumar MS; Song JS; Lee JC; Tsai CH; Chen CT; Liu YW; Chao YS; Wu SY
J Med Chem; 2010 Dec; 53(24):8770-4. PubMed ID: 21090651
[TBL] [Abstract][Full Text] [Related]
54. Identification of a new series of non-peptidic NK3 receptor antagonists.
Juhl K; Hansen T; Kehler J; Khanzhin NA; Nørgaard MB; Ruhland T; Larsen DB; Jensen KG; Steiniger-Brach B; Nielsen SM; Simonsen KB
Bioorg Med Chem Lett; 2011 Mar; 21(5):1498-501. PubMed ID: 21292483
[TBL] [Abstract][Full Text] [Related]
55. 2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor.
Giardina GA; Sarau HM; Farina C; Medhurst AD; Grugni M; Foley JJ; Raveglia LF; Schmidt DB; Rigolio R; Vassallo M; Vecchietti V; Hay DW
J Med Chem; 1996 Jun; 39(12):2281-4. PubMed ID: 8691422
[No Abstract] [Full Text] [Related]
56. Design and synthesis of potential dual NK(1)/NK(3) receptor antagonists.
Hanessian S; Babonneau V; Boyer N; Mannoury la Cour C; Millan MJ; De Nanteuil G
Bioorg Med Chem Lett; 2014 Jan; 24(2):510-4. PubMed ID: 24374277
[TBL] [Abstract][Full Text] [Related]
57. Discovery of 3-aryl-5-acylpiperazinyl-pyrazoles as antagonists to the NK3 receptor.
Hoveyda HR; Roy MO; Blanc S; Noël S; Salvino JM; Ator MA; Fraser G
Bioorg Med Chem Lett; 2011 Apr; 21(7):1991-6. PubMed ID: 21376585
[TBL] [Abstract][Full Text] [Related]
58. Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety.
Giuliani G; Cappelli A; Matarrese M; Masiello V; Turolla EA; Monterisi C; Fazio F; Anzini M; Pericot Mohr G; Riitano D; Finetti F; Morbidelli L; Ziche M; Giorgi G; Vomero S
Bioorg Med Chem; 2011 Apr; 19(7):2242-51. PubMed ID: 21421318
[TBL] [Abstract][Full Text] [Related]
59. Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 - 2010).
Malherbe P; Ballard TM; Ratni H
Expert Opin Ther Pat; 2011 May; 21(5):637-55. PubMed ID: 21417773
[TBL] [Abstract][Full Text] [Related]
60. Identification of a crucial amino acid in the helix position 6.51 of human tachykinin neurokinin 1 and 3 receptors contributing to the insurmountable mode of antagonism by dual NK₁/NK₃ antagonists.
Bissantz C; Bohnert C; Hoffmann T; Marcuz A; Schnider P; Malherbe P
J Med Chem; 2012 Jun; 55(11):5061-76. PubMed ID: 22574973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
